Background-Non-steroidal anti-inflammatory drugs (NSAIDs) are effective for
arthritis but cause gastrointestinal injury. Bovine colostrum is a rich so
urce of growth factors and is marketed as a health food supplement.
Aims-To examine whether spray dried, defatted colostrum or milk preparation
s could reduce gastrointestinal injury caused by indomethacin.
Methods-Effects of test solutions, administered orally, were examined using
an indomethacin restraint rat model of gastric damage and an indomethacin
mouse model of small intestinal injury. Effects on migration of the human c
olonic carcinoma cell line HT-29 and rat small intestinal cell line RIE-1 w
ere assessed using a wounded monolayer assay system (used as an in vitro mo
del of wound repair) and effects on proliferation determined using [H-3]thy
midine incorporation.
Results-Pretreatment with 0.5 or 1 ml colostral preparation reduced gastric
injury by 30% and 60% respectively in rats. A milk preparation was much le
ss efficacious. Recombinant transforming growth factor beta added at a dose
similar to that found in the colostrum preparation (12.5 ng/rat), reduced
injury by about 60%. Addition of colostrum to drinking water (10% vol/vol)
prevented villus shortening in the mouse model of small intestinal injury.
Addition of milk preparation was ineffective. Colostrum increased prolifera
tion and cell migration of RIE-1 and HT-29 cells. These effects were mainly
due to constituents of the colostrum with molecular weights greater than 3
0 kDa.
Conclusions-Bovine colostrum could provide a novel, inexpensive approach fo
r the prevention and treatment of the injurious effects of NSAIDs on the gu
t and may also be of value for the treatment of other ulcerative conditions
of the bowel.